{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0005298,73,MONDO:0005298,170,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0005298","source":"MONDO:0005298|osteoporosis","targets":["NCT00006180|Bone Loss in Premenopausal Women With Depression|COMPLETED|PHASE4|INTERVENTIONAL","NCT00035256|Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00035971|EVA: Evista Alendronate Comparison|COMPLETED|PHASE4|INTERVENTIONAL","NCT00114556|The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00130403|OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT00148915|A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo|COMPLETED|PHASE4|INTERVENTIONAL","NCT00157690|Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00159419|Bisphosphonate Therapy for Osteogenesis Imperfecta|COMPLETED|PHASE4|INTERVENTIONAL","NCT00165607|Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00168909|Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00182871|Testosterone Effects on Bone and Frailty|COMPLETED|PHASE4|INTERVENTIONAL","NCT00191425|2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00211211|FREE Study - Fracture Reduction Evaluation|COMPLETED|PHASE4|INTERVENTIONAL","NCT00221299|Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use|COMPLETED|PHASE4|INTERVENTIONAL","NCT00252408|Danish Osteoporosis Prevention Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00259298|Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00261625|Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?|COMPLETED|PHASE4|INTERVENTIONAL","NCT00271713|Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00294463|Effects of Tibolone Treatment on the Endometrium|COMPLETED|PHASE4|INTERVENTIONAL","NCT00327990|Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate|COMPLETED|PHASE4|INTERVENTIONAL","NCT00357331|The Effects of Potassium Citrate on Bone Metabolism|COMPLETED|PHASE4|INTERVENTIONAL","NCT00371956|Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00372372|The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment|COMPLETED|PHASE4|INTERVENTIONAL","NCT00376662|HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00402441|Risedronate in the Prevention of Osteoporosis in Postmenopausal Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT00405392|Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00431444|Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density|COMPLETED|PHASE4|INTERVENTIONAL","NCT00446589|The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density|TERMINATED|PHASE4|INTERVENTIONAL","NCT00453492|Risedronate Sodium in Post Menopausal Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00460057|The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss|COMPLETED|PHASE4|INTERVENTIONAL","NCT00479037|Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00485953|Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00489424|Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass|COMPLETED|PHASE4|INTERVENTIONAL","NCT00491920|High Dosage Vitamin D and Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00504166|Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT00530582|Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT00544180|ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week|TERMINATED|PHASE4|INTERVENTIONAL","NCT00548509|The Effect of Vitamin K2 on Bone Turnover|COMPLETED|PHASE4|INTERVENTIONAL","NCT00549068|POWER Point of Care Effect on Satisfaction of Treatment|COMPLETED|PHASE4|INTERVENTIONAL","NCT00549965|Satisfaction and Compliance of Risedronate in PMO|COMPLETED|PHASE4|INTERVENTIONAL","NCT00557310|A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide|COMPLETED|PHASE4|INTERVENTIONAL","NCT00560443|RCT on Ketorolac and Tramadol in Bone Fractures Pain of Child|COMPLETED|PHASE4|INTERVENTIONAL","NCT00577395|Bone Microarchitecture in Osteopenic Postmenopausal Women|TERMINATED|PHASE4|INTERVENTIONAL","NCT00581828|Does Treatment of Hypovitaminosis D Increase Calcium Absorption?|COMPLETED|PHASE4|INTERVENTIONAL","NCT00582972|Does Omeprazole Decrease Intestinal Calcium Absorption?|COMPLETED|PHASE4|INTERVENTIONAL","NCT00592917|OSTPRE-Fracture Prevention Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00616694|Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00632216|A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00634686|Effects of Omega-3 Fatty Acids on Bone and Frailty|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00664053|Effects of DHEA/Exercise on Bone, Muscle and Balance|COMPLETED|PHASE4|INTERVENTIONAL","NCT00668447|Soy and Isoflavones Effect on Bone|COMPLETED|PHASE4|INTERVENTIONAL","NCT00701337|Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route|COMPLETED|PHASE4|INTERVENTIONAL","NCT00719160|The Effect of Protein on Calcium Absorption and Gastric Acid Production|COMPLETED|PHASE4|INTERVENTIONAL","NCT00727493|Osteoporosis and Dental Implant|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00745485|Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid|COMPLETED|PHASE4|INTERVENTIONAL","NCT00766532|Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?|COMPLETED|PHASE4|INTERVENTIONAL","NCT00790101|Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation|TERMINATED|PHASE4|INTERVENTIONAL","NCT00826228|Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00860964|A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT00869622|Antiepileptic Drugs and Osteoporotic Prevention Trial|COMPLETED|PHASE4|INTERVENTIONAL","NCT00887354|A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture|COMPLETED|PHASE4|INTERVENTIONAL","NCT00892606|Methadone Versus Morphine for Orthopedic Surgery Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00939874|Switch From Tenofovir to Raltegravir for Low Bone Mineral Density|COMPLETED|PHASE4|INTERVENTIONAL","NCT00969839|NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01166958|Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?|COMPLETED|PHASE4|INTERVENTIONAL","NCT01222026|Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate|COMPLETED|PHASE4|INTERVENTIONAL","NCT01267279|Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty|COMPLETED|PHASE4|INTERVENTIONAL","NCT01287533|Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids|COMPLETED|PHASE4|INTERVENTIONAL","NCT01293292|Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action|COMPLETED|PHASE4|INTERVENTIONAL","NCT01350934|A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01360424|Teriparatide Treatment in Patients With Inherited Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01378689|Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids|COMPLETED|PHASE4|INTERVENTIONAL","NCT01430104|A Study of Teriparatide in Japanese Osteoporosis Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT01465568|Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01535027|Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01544725|Ketamine-propofol Versus Ketamine Alone for Procedural Sedation in Adults|COMPLETED|PHASE4|INTERVENTIONAL","NCT01574833|Early Application of Pulsed Electromagnetic Field in the Treatment of Postoperative Delayed Union|COMPLETED|PHASE4|INTERVENTIONAL","NCT01675297|Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01679899|Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability|COMPLETED|PHASE4|INTERVENTIONAL","NCT01698164|Multi-centre Clinical Trial on Hormone Replacement Treatment in China|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01705587|Fracture (FX) Improvement With Teriparatide: FiX-IT Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT01731340|A Study on the Impact of Calcium on Woman's Vascular Health|COMPLETED|PHASE4|INTERVENTIONAL","NCT01753856|Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01765010|The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01841814|Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT01882400|Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy|COMPLETED|PHASE4|INTERVENTIONAL","NCT01904110|To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT01983475|Denosumab Administration After Spinal Cord Injury|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02013986|Effects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02035774|A Novel Selective Block of the Suprascapular Nerve|COMPLETED|PHASE4|INTERVENTIONAL","NCT02090400|Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT02130973|The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02139007|Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT02156960|Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02156999|Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02280291|Single Shot Versus OnQ Pump in Extremity Fractures|COMPLETED|PHASE4|INTERVENTIONAL","NCT02342015|Effect of Atorvastatin on Bone-vascular Axis|COMPLETED|PHASE4|INTERVENTIONAL","NCT02357277|The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT02371252|Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment|COMPLETED|PHASE4|INTERVENTIONAL","NCT02416271|The Forteo Alendronate Comparator Trial|COMPLETED|PHASE4|INTERVENTIONAL"]}]}